Catalase: The golden key to regulate oxidative stress in breast cancer

doi:10.5306/wjco.v16.i10.110126

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (54)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

HTML

Figures (1-3)

Sum=39

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=3

Oct 24, 2025 (publication date) through Oct 27, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Oct 24, 2025; 16(10): 110126
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.110126

Catalase: The golden key to regulate oxidative stress in breast cancer

Jia-Wei Liu, Wen-Jia Chen, Yang-Zheng Lan, Jing Liu

Jia-Wei Liu, Wen-Jia Chen, Yang-Zheng Lan, Jing Liu, The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China

Co-first authors: Jia-Wei Liu and Wen-Jia Chen.

Author contributions: Liu J designed this study; Liu JW and Chen WJ searched the publication, prepared the draft of the manuscript as the co-first authors of the paper; Liu JW, Chen WJ, and Lan YZ prepared the figures; Liu J revised the manuscript critically; Liu JW, Chen WJ, Lan YZ, and Liu J interpreted the results, constructed the structure of the review, and prepared the tables; and all authors have read and approve the final manuscript.

Supported by National Natural Science Foundation of China, No. 82273457; Natural Science Foundation of Guangdong Province, No. 2023A1515012762; and Science and Technology Special Project of Guangdong Province, No. 210715216902829.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Jing Liu, MD, PhD, Associate Professor, The Breast Center, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515041, Guangdong Province, China. jliu12@stu.edu.cn

Received: May 30, 2025
Revised: June 25, 2025
Accepted: September 17, 2025
Published online: October 24, 2025
Processing time: 148 Days and 0.9 Hours

Core Tip

Core Tip: Catalase (CAT) plays a critical role in breast cancer (BC) by regulating oxidative stress. Its expression is regulated by hormone receptors and epigenetics and is closely related to the metastatic site and prognosis of BC. Therapeutic strategies targeting CAT provides a potential promising new avenue for advancing BC treatment.